Impact Of Rising Obesity Rates On The Growth Of The Ventral Hernia Treatment Market: A Significant Driver Propelling The Ventral Hernia Treatment Market In 2025

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Ventral Hernia Treatment Market Size and Projected Growth Rate?
The market size for ventral hernia treatment has seen significant growth in the past few years. It is expected to rise from $4.87 billion in 2024 to $5.23 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The historic growth can be linked to factors such as the rising rates of obesity, greater awareness of ventral hernias, an aging population, growth in disposable income and a rising demand for minimally invasive surgical procedures.

The forecast for the ventral hernia treatment market remains promising, with substantial growth expected in the immediate future. The industry is estimated to reach a worth of $6.90 billion in 2029, expanding at a compound annual growth rate (CAGR) of 7.2%. The factors prompting this projected growth include a heightened demand for outpatient processes, increased healthcare expenditure, governmental initiatives, a rising need for hernia repair surgeries, and escalating investments in R&D. The period foresees trends like advanced hernia repair devices, the usage of bioabsorbable materials, strategic partnerships, the emergence of robotic-assisted surgery tools, and remote patient monitoring.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21315

What Are the Major Segments in the Ventral Hernia Treatment Market?
The ventral hernia treatment market covered in this report is segmented -

1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia
2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery
4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics

Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp

What Are The Driving Ventral Hernia Treatment Market Evolution?
As the occurrence of obesity continues to rise, the ventral hernia treatment market is expected to grow in response. Obesity, which significantly affects a person's health, is characterized as a condition where an individual has an excessive accumulation of body fat due to factors such as poor diet, inactive lifestyle, heredity, lack of exercise, environment, and stress. Given the health complications associated with obesity like strain on the abdominal wall, risk of hernia recurrence and the need for improved abdominal strength for mobility and better lifestyle choices, ventral hernia treatment serves as a beneficial measure for those grappling with obesity. For instance, in March 2024, a report from the World Health Organization WHO, based in Switzerland, stated that about one in eight people around the globe, including 2.5 billion adults over the age of 18, were facing obesity, of whom 890 million were living with the condition. The report identified 43% of adults as overweight, while 16% were classified as obese. Furthermore, the number of overweight children below the age of 5 was considered as 37 million. Consequently, the rise in obesity contributes to the growth of the ventral hernia treatment market.

Which Firms Dominate The Ventral Hernia Treatment Market Segments?
Major companies operating in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.

What Are the Major Trends Shaping the Ventral Hernia Treatment Market?
Prominent organizations in the ventral hernia treatment market are prioritizing the development of technological advancements, including laparoscopic and open hernia mesh fixation devices, aiming to enhance surgical results, minimize complications, and boost patient recovery. These fixation devices refer to specialized medical instruments that secure mesh during surgical procedures to repair hernias. They can be utilized in either minimally invasive (laparoscopic) methods or traditional open surgical techniques. For example, in March 2024, TELA Bio Inc., an American medical technology firm, launched the LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices in the U.S. The LIQUIFIX FIX8 is designed for minimally invasive repairs, whereas the LIQUIFIX precision is intended for open femoral and inguinal hernia repairs. These FDA-sanctioned devices use liquid anchors to secure the mesh without penetrating the tissue, thereby decreasing trauma and possible complications. With around 1.2 million hernia surgeries conducted annually in the U.S., LIQUIFIX provides accuracy and safety in delicate areas while reducing the risk of vascular or nerve damage.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report

Which Is The Largest Region In The Ventral Hernia Treatment Market?
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Ventral Hernia Treatment Market?
2. What is the CAGR expected in the Ventral Hernia Treatment Market?
3. What Are the Key Innovations Transforming the Ventral Hernia Treatment Industry?
4. Which Region Is Leading the Ventral Hernia Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.